Psychemedics Stock Forecast, Price & News

Psychemedics (NASDAQ:PMD) Frequently Asked Questions

How has Psychemedics' stock been impacted by COVID-19?

Psychemedics' stock was trading at $6.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PMD stock has increased by 2.7% and is now trading at $7.14.
View which stocks have been most impacted by COVID-19.

When is Psychemedics' next earnings date?

Psychemedics is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022.
View our earnings forecast for Psychemedics.

How were Psychemedics' earnings last quarter?

Psychemedics Co. (NASDAQ:PMD) announced its earnings results on Friday, November, 12th. The company reported $0.13 EPS for the quarter. The company earned $6.67 million during the quarter. Psychemedics had a net margin of 1.73% and a trailing twelve-month return on equity of 3.15%.
View Psychemedics' earnings history.

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics declared a quarterly dividend on Friday, December 10th. Stockholders of record on Monday, December 20th will be given a dividend of $0.05 per share on Thursday, December 30th. This represents a $0.20 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date is Friday, December 17th.
View Psychemedics' dividend history.

Is Psychemedics a good dividend stock?

Psychemedics pays an annual dividend of $0.20 per share and currently has a dividend yield of 2.81%. The dividend payout ratio of Psychemedics is 333.39%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Psychemedics' dividend history.

Who are Psychemedics' key executives?

Psychemedics' management team includes the following people:

• Raymond C. Kubacki, Chairman, President & Chief Executive Officer
• Charles M. Doucot, Executive Vice President
• Sarah E. Ashby, Vice President & General Counsel
• Andrew Limbek, Vice President & Controller
• Michael I. Schaffer, Vice President-Laboratory Operations

What is Raymond C. Kubacki Jr.'s approval rating as Psychemedics' CEO?

6 employees have rated Psychemedics CEO Raymond C. Kubacki Jr. on Glassdoor.com. Raymond C. Kubacki Jr. has an approval rating of 67% among Psychemedics' employees.

Who are some of Psychemedics' key competitors?

Some companies that are related to Psychemedics include Exagen (XGN), MDxHealth (MDXH), Biocept (BIOC), OpGen (OPGN), Vyant Bio (VYNT), CannLabs (CANL), PharmChem (PCHM), AnPac Bio-Medical Science (ANPC), American Shared Hospital Services (AMS), American Shared Hospital Services (AMS), Zicix (ZICX), First Choice Healthcare Solutions (FCHS), PotNetwork (POTN), ACI Global (ACGJ) and Aeon Global Health (AGHC).
View all of PMD's competitors.

What other stocks do shareholders of Psychemedics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), Dominion Energy (D), Sorrento Therapeutics (SRNE), AT&T (T), AbbVie (ABBV), (CGC), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pattern Energy Group (PEGI) and Simon Property Group (SPG).

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

How do I buy shares of Psychemedics?

Shares of PMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Psychemedics' stock price today?

One share of PMD stock can currently be purchased for approximately $7.14.

How much money does Psychemedics make?

Psychemedics has a market capitalization of $39.57 million and generates $21.36 million in revenue each year. The company earns $-3.86 million in net income (profit) each year or $0.06 on an earnings per share basis.

How many employees does Psychemedics have?

Psychemedics employs 138 workers across the globe.

When was Psychemedics founded?

Psychemedics was founded in 1985.

What is Psychemedics' official website?

The official website for Psychemedics is www.psychemedics.com.

Where are Psychemedics' headquarters?

Psychemedics is headquartered at 289 GREAT ROAD Suite 200, ACTON MA, 01720.

How can I contact Psychemedics?

Psychemedics' mailing address is 289 GREAT ROAD Suite 200, ACTON MA, 01720. The company can be reached via phone at (978) 206-8220 or via fax at 978-264-9236.